NCT00045734 2017-05-15Imatinib Mesylate in Treating Patients With Recurrent MeningiomaNational Cancer Institute (NCI)Phase 2 Completed23 enrolled 9 charts
NCT00354913 2013-01-18Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive MeningiomaDuke UniversityPhase 2 Completed21 enrolled 8 charts